Exagen Inc. (XGN) investor relations documents from the company's IR site: 2 presentations, 13 press releases; latest deck 2026-06-02. Read in-app with summaries. First-party data.
Q1 2026 Earnings Presentation: Exagen Q1 2026 update reports $17.3M revenue, up 12% YoY, driven by adoption of its AVISE autoimmune diagnostic testing platform.
XGN overview · XGN earnings · XGN financials · XGN KPIs · XGN documents · XGN ownership · XGN peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.